. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "7455113" . . . . . . . . "The role of Interleukin 6 inhibitors in therapy of severe COVID-19"@en . . . . . "10.1016/J.BIOPHA.2020.110698" . . . . "131" . . . . . . . . . . . . . "The role of Interleukin 6 inhibitors in therapy of severe COVID-19"@en . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "scientific article published on 28 August 2020"@en . . "M Samsonov" . . . . . . "32920514" . . . . "The role of Interleukin 6 inhibitors in therapy of severe COVID-19"@nl . . . . . . . . . . . . . . . . . "The role of Interleukin 6 inhibitors in therapy of severe COVID-19"@en . . . . . . . . . . . . . . . . . . . . . . . . . "110698" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "The role of Interleukin 6 inhibitors in therapy of severe COVID-19"@en . . . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u n'agostu de 2020"@ast . . . . . . "2020-08-28T00:00:00Z"^^ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "wetenschappelijk artikel"@nl . . . "E Nasonov" . . . . . . . . . . . "The role of Interleukin 6 inhibitors in therapy of severe COVID-19"@nl . . "The role of Interleukin 6 inhibitors in therapy of severe COVID-19"@nl . . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 28 \u0441\u0435\u0440\u043F\u043D\u044F 2020"@uk . .